EUROPEAN biologics contract development and manufacturing organisation Rezon Bio has appointed Dr Ralf Otto as its Chief Operating Officer.
He will be responsible for the operational areas of clinical and commercial cGMP manufacturing, development, quality, engineering and business operations across Rezon Bio’s integrated end-to-end CDMO platform.
Dr Ralf Otto said: “There is a clear need for reliable, highly price-competitive CDMOs to drive innovation, and my focus will be on delivering a seamless, responsive, and high-quality experience for clients across the full biologics lifecycle.”
Dr Adriana Kiędzierska-Mencfeld, Rezon Bio’s Chief Executive Officer, added: “I’m pleased Ralf Otto is taking on the role of Chief Operating Officer as Rezon Bio enters its next phase of growth. His international experience across biologics development, manufacturing, and organizational transformation, combined with his pragmatic leadership style and strong execution focus, will be instrumental as we continue strengthening our integrated capabilities, enhancing execution across the organisation and delivering an exceptional service experience, scalability, and reliability to our clients.”